MediStem Laboratories, Inc. to Present on Its Progress in Its Menstrual Derived Stem Cell Program (ERC)

SAN DIEGO, CA and SCOTTSDALE, AZ--(Marketwire - May 06, 2008) - Medistem Laboratories, Inc. (OTCBB: MDSM), a biotechnology company dedicated to commercialization of its novel, universal donor, stem cell population, the Endometrial Regenerative Cell (ERC), is pleased to announce its upcoming presentation at the BioFinance 2008 meeting.

MORE ON THIS TOPIC